Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia

Journal of Virology

Volumn 86, Issue 16, 2012, Pages 8461-8471

  Sais, Giovanni ^a   Wyler, Stephen ^b   Hudolin, Tvrtko ^b,e   Banzola, Irina ^a   Mengus, Chantal ^b   Bubendorf, Lukas ^b   Wild, Peter J ^c   Hirsch, Hans H ^d   Sulser, Tullio ^a   Spagnoli, Giulio C ^b   Provenzano, Maurizio ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 7 RECEPTOR; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; VIRUS LARGE T ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BK VIRUS; CANCER GROWTH; CANCER RECURRENCE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DOWN REGULATION; EPSTEIN BARR VIRUS; FOLLOW UP; GAMMA INTERFERON GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA VIRUS; INTERLEUKIN 10 GENE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN SECRETION; TRANSFORMING GROWTH FACTOR BETA1 GENE; UPREGULATION;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIGENS, NEOPLASM; BK VIRUS; CYTOKINES; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; VIRAL PROTEINS;

EID: 84865106385     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00005-12     Document Type: Article

References (56)

1. Abend JR, Jiang M, Imperiale MJ. 2009. BK virus and human cancer: innocent until proven guilty. Semin. Cancer Biol. 19:252-260.
2. + regulatory T cells. Semin. Immunol. 16:89-98.
3. Balis V, et al. 2007. Prevalence of BK virus and human papillomavirus in human prostate cancer. Int. J. Biol. Markers 22:245-251.
4. Bargonetti J, Reynisdottir I, Friedman PN, Prives C. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6:1886-1898.
5. Bergh J, et al. 2007. No link between viral findings in the prostate and subsequent cancer development. Br. J. Cancer 96:137-139.
6. Bocchetta M, et al. 2008. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res. 68:1022-1029.
7. Bodaghi S, et al. 2009. Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. J. Clin. Microbiol. 47:2577-2585.
8. Bronte V, et al. 2005. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med. 201:1257-1268.
9. Burdin N, Peronne C, Banchereau J, Rousset F. 1993. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med. 177:295-304.
10. Chen Q, Daniel V, Maher DW, Hersey P. 1994. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer 56:755-760.
11. Currier JR, et al. 2002. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J. Immunol. Methods 260:157-172.
12. Das D, Shah RB, Imperiale MJ. 2004. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene 23:7031-7046.
13. Das D, Wojno K, Imperiale MJ. 2008. BK virus as a cofactor in the etiology of prostate cancer in its early stages. J. Virol. 82:2705-2714.
14. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. 1999. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am. J. Pathol. 155:1985-1992.
15. De Marzo AM, et al. 2007. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7:256-269.
16. Dong JT. 2006. Prevalent mutations in prostate cancer. J. Cell Biochem. 97:433-447.
17. + lymphocyte clusters. Eur. J. Cancer 45:1664-1672.
18. + regulatory T cells in hepatitis C virus infection. J. Virol. 82:5043-5053.
19. Feder-Mengus C, et al. 2008. High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. Eur. J. Cancer 44:2266-2275.
20. + T cells. J. Immunol. 168:2247-2254.
21. Gastl GA, et al. 1993. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55:96-101.
22. Gosert R, et al. 2008. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J. Exp. Med. 205:841-852.
23. Gretzer MB, Trock BJ, Han M, Walsh PC. 2002. A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria. J. Urol. 168:1419-1422.
24. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
25. Hoffman NG, Cook L, Atienza EE, Limaye AP, Jerome KR. 2008. Marked variability of BK virus load measurement using quantitative realtime PCR among commonly used assays. J. Clin. Microbiol. 46:2671-2680.
26. Imperiale MJ. 2000. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology 267:1-7.
27. Imperiale MJ. 2001. Oncogenic transformation by the human polyomaviruses. Oncogene 20:7917-7923.
28. Iyer JG, et al. 2011. Merkel cell polyomavirus-specific CD8 and CD4 T-cell responses identified in Merkel cell carcinomas and blood. Clin. Cancer Res. 17:6671-6680.
29. Jemal A, et al. 2011. Global cancer statistics. CA Cancer J. Clin. 61:69-90.
30. Joosten SA, Ottenhoff TH. 2008. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum. Immunol. 69:760-770.
31. + T-cell activation and high viral load. J. Virol. 81:13444-13455.
32. + regulatory T cells mediate immunosuppression in prostate cancer. Clin. Cancer Res. 13:6947-6958.
33. Leuenberger D, et al. 2007. Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored. Clin. Vaccine Immunol. 14:959-968.
34. + CT method. Methods 25: 402-408.
35. + regulatory T cells. J. Immunol. 186:4535-4540.
36. + CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J. Immunol. 177:7398-7405.
37. Monini P, et al. 1995. DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology 214:273-279.
38. Paulson KG, et al. 2010. Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients. Cancer Res. 70:8388-8397.
39. + BKV-seropositive donors. J. Transl. Med. 4:47.
40. Provenzano M, et al. 2006. MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts. Trends Mol. Med. 12:465-472.
41. + T cells across a wide range of HLA specificities. J. Cell Mol. Med. 13:2131-2147.
42. Putzi MJ, De Marzo AM. 2000. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 56:828-832.
43. Randhawa PS, et al. 2002. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 74:485-488.
44. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68-79.
45. Rubinstein R, Schoonakker BC, Harley EH. 1991. Recurring theme of changes in the transcriptional control region of BK virus during adaptation to cell culture. J. Virol. 65:1600-1604.
46. Schwele S, et al. 2012. Cytomegalovirus-specific regulatory and effector T cells share TCR clonality-possible relation to repetitive CMV infections. Am. J. Transplant. 12:669-681.
47. +. Prostate 69:1694-1703.
48. Stockis J, Colau D, Coulie PG, Lucas S. 2009. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur. J. Immunol. 39:3315-3322.
49. + T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 12:327-334.
50. Touze A, et al. 2011. High levels of antibodies against Merkel cell polyomavirus identify a subset of patients with Merkel cell carcinoma with better clinical outcome. J. Clin. Oncol. 29:1612-1619.
51. Vence L, et al. 2007. Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma. Proc. Natl. Acad. Sci. U. S. A. 104: 20884-20889.
52. +regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:971-979.
53. + T cells induced by TCR triggering or homeostatic cytokines. Eur. J. Immunol. 36:296-304.
54. Weinreb DB, et al. 2006. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn. Cytopathol. 34:201-203.
55. + regulatory T cells in the peripheral blood of patients with prostate cancer. Clin. Cancer Res. 14:1032-1040.
56. + regulatory T cells. PLoS One 7:e34547. doi:10.1371/ journal.pone.0034547.